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INTRODUCTION 
Stroke is the second leading cause of death worldwide 
which is considered as the third one in the United States 
and other industrialized countries.1 Each year, 55 million 
deaths occur in the world that 10% of them are caused by 
stroke. In the United States, about 780,000 strokes occur 
each year.2-4  
The deaths occurring within 28 days after the stroke in 
the Middle East and North Africa vary from 10% in 
Kuwait to 31.5% in Iran. Two-thirds of all strokes occur 
in the developing countries which, in spite of their 
preventable nature, are increasingly becoming a major 
health problem. It is expected that the deaths resulting 
from stroke will nearly double in the Middle East and 
North Africa by 2030.4 
Stroke is the second cause of death in the world that 
causing the death of 6 million people yearly. In Iran daily 
250-300 persons suffering to strike and other person with 
mild stroke symptoms not referred to hospital.5 
Statistics showed that 30 - 40% of persons which live 
after stroke suffering to severe disabilities. Severity and 
type of disorders related to location, extent and type of 
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caught artery which from them Hemiparesis is 
common.6,7 Studies showed that various factors and 
diseases deal to hemorrhagic stroke.8,9 Hemorrhagic 
strokes include 10 - 20% of strokes that its incidence rate 
in world was 24.6 per 1000.10,11 
After hemorrhagic stroke about third of patients dead in 
the first month and 40% of them have ICH (intracerebral 
hemorrhage) and 30% have SAH (subarachnoid 
hemorrhage).12-14 
Treatment of patients in the golden time is important and 
several studies have been studied the chemical and herbal 
treatments in this context.15 
Aacetazolamide is one of the drugs used for carbonic 
anhydrase inhibitors and can be reduced brain edema and 
death of neurons. Also this drug causing a significant 
increase in cerebral blood flow (CBF) and thereby 
increase the oxygen supply in the first minutes after 
use.16-17 
The aim of this study was to assessment the effect of 
acetazolamide on the signs recovery rate, decreasing 
Rankin scale and mortality rate in patients with 
intracerebral hemorrhage.  
METHODS 
This is a double blind clinical trial (patients and samplers 
not informed the type of drug) that has been done on 120 
stroke patients with intracerebral hemorrhage in 2014-
2015. Study has been done after confirmed study design 
by ethical committee of university. 
Patients with inclusion criteria such as age > 40, non-
history of stroke and heart and liver and digestive 
diseases after confirmation there stroke by neurologist 
and doing CT-Scan divided randomly in two groups each 
with 60 patients. Patients in intervention group take 
acetazolamide 750 mg/day and in control group take 
placebo. 
The drug and placebo administration for two groups 
repeated each 8 hour. The status of patients investigated 
by Rankin scale in three times in baseline, 72 hours and 3 
weeks after intracerebral hemorrhage. Data collected by a 
checklist and analyzed by statistical methods in SPSS.19. 
RESULTS 
Of all patients, 49 (40.8%) were male and 71 (59.1%) 
were female and the difference was statistically 
significant between two groups. Putamen hemorrhage is 
the most location for intracerebral hemorrhage (n = 43, 
35.8%).  
The prevalence rate of disease in age group 70 - 80 years 
was the most (n = 53, 44.1%) and from them 52.8% were 
male (Table 1). 
According to the Rankin scale, 53 (44.2%) of patients 
were in the status 5 “moderately severe disability. Unable 
to attend to own bodily needs without assistance, and 
unable to walk unassisted” in baseline. In the intervention 
group after 72 hour and three week, the recovery rate 
significantly more than control group based on Rankin 
scale (Table 2). 
Table 1: Prevalence of intracereberal hemorrhage in 
patients by age and sex. 
Total  Male  Female Age 
group % n % n % n 
9.2 11 8.2 4 9.9 7 40-50 
11.7 14 12.2 6 11.3 8 50-60 
18.4 22 14.3 7 21.1 15 60-70 
44.2 53 51 25 39.4 28 70-80 
16.7 20 14.3 7 18.3 13 80-90 
100 120 40.8 49 59.2 71 Total  
Table 2. Status of stroke patients referred with 
intracerebral hemorhhage symptoms in baseline by 
rankin scale. 
% n Definition  
Scale 
score 
0 0 No symptoms. 0 
0.83 1 
No significant disability. Able 
to carry out all usual 
activities, despite some 
symptoms. 
1 
5 6 
Slight disability. Able to look 
after own affairs without 
assistance, but unable to carry 
out all previous activities. 
2  
11.7 14 
Moderate disability. Requires 
some help, but able to walk 
unassisted. 
3  
44.2 53 
Moderately severe disability. 
Unable to attend to own 
bodily needs without 
assistance, and unable to walk 
unassisted. 
4  
35.8 43 
Severe disability. Requires 
constant nursing care and 
attention, bedridden, 
incontinent. 
5  
2.5 3 Dead 6  
Of all patients, 4 (3.33%) have complications midline 
shift and 1 (0.83%) patients have intracranial and 
abdominal bleeding (IVH). 
According Rankin scale, after 72 hour in intervention 
group the rate of one unit recovery with 56.7% 
significantly more than control group with 35%                 
(Table 3). 
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According Rankin scale, after three weeks in intervention 
group the rate of two unit recovery with 45% 
significantly more than control group with 8.3%                
(Table 4). 
 
Table 3: Recovery rate (change in rankin scale to better status) of patients after entry to study by groups and 
location of intracerebral hemorrhage. 
Total  1 unit recovery   Without change  Rankin scale 
Location  % n Control  Intervention  Control  Intervention  
15 18 0 7 8 3 Thalamus  
35.8 43 6 12 11 14 Putamen  
4.2 5 3 1 1 0 Pons  
10.8 13 2 1 9 1 Cerebellum 
25.8 31 8 13 6 4 Lobar  
5 6 2 0 3 1 Gaudate  
3.3 4 0 0 1 23 IVH  
100 120 21 34 39 26 Total  
P = 0.039 
Table 4: Recovery rate (change in Rankin scale to better status) of patients three weeks after study by groups and 
location of intracerebral hemorrhage. 
Two unit recovery One unit recovery  Without change  Rankin scale 
location  Control Intervention Control  Intervention  Control  Intervention  
0 5 8 5 0 0 Thalamus  
4 12 13 14 0 0 Putamen  
0 1 3 0 1 0 Pons  
0 1 11 1 0 0 Cerebellum 
1 8 13 9 0 0 Lobar  
0 0 4 1 1 0 Coditis  
0 0 1 1 0 2 IVH  
5 27 53 31 2 2 Total  
P=0.001 
DISCUSSION 
In the study the significant effect of acetazolamide 
compared with placebo on stroke, due to lack of similar 
research in the field of acetazolamide effect on 
intracerebral hemorrhage compare the results of this 
study with other studies may not make sense. But 
according the obtained results from this study, we can 
resulted that acetazolamide is a better drug for stroke and 
our study results consist with Sharafadinzadeh and et al 
study.18 In this study most of stroke patients similar to 
other studies were female (59.1%).19,20 In terms of 
conflict the result of this study in line with rahman and et 
al study and in two study the most of conflict was in 
Putamen and the least was in Sia and also in all age 
groups the results was similar.19 
In this study the rate of mortality significantly decreased 
by using acetazolamid and our study in line with Fuyou 
and et al study.21 In this study the rate of mortality in 
using acetazolamid in increasing blood flow and better 
performance of brain was confirmed and our study results 
in line with Bothun and et al study.22 
 
CONCLUSION 
Acetazolamide can be effective in treatment hemorrhagic 
stroke, decreasing Rankin scale and mortality rate in 
patients with cerebral hemorrhage. It was recommended 
that in future studies this drug used on big sample of 
patients for reach to better positive results in using 
acetazolamide. 
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